CVE-2015-3965
Pfizer Symbiq Infusion System Firmware vulnerability
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Affected products
Symbiq Infusion System Firmware. The exact versions are in the references.
What to do now
- Check your exposureFind out whether Pfizer Symbiq Infusion System Firmware runs anywhere in your environment, including systems of suppliers.
- UpdateInstall the version in which the vendor fixed the vulnerability. The references lead to the advisory.
- Set the orderSystems that can be reached from the internet come first, then the rest.
References
Data: CVE list and the NVD. This product uses data from the NVD API but is not endorsed or certified by the NVD.